Table 3.
Presentation, treatment strategies, and outcomes of patients with endophthalmitis caused by Corynebacterium.
| No | Pre- infection VA | Initial VA | IOP | Initial Tx | Initial Intravitreal Injection(s) | Additional Tx (Days After Initial Tx) | Additional Intravitreal Injections | Last VA | Follow-up Time |
|---|---|---|---|---|---|---|---|---|---|
| 1 | UK | CF | 14 | T+I | VANC + CTZ + DEX | None | None | 20/40 | 12 mos |
| 2 | 20/40 | 1/200 | 22 | T+I | VANC + CTZ + DEX | PPV (6) | VANC + CTZ | 20/60 | 9 mos |
| 3 | UK | 7/200 | 16 | PPV | VANC + CTZ + DEX | None | None | 20/20 | 4 mos |
| 4 | UK | LP | - | T+I | VANC + CTZ + DEX | Enuc (17) | None | Enuc | 42 mos |
| 5 | UK | HM | 14 | PPV | VANC + CTZ + DEX | None | None | 20/40 | 30 mos |
| 6 | 20/80 | CF | 8 | PPV | VANC + DEX | None | None | 20/400 | 1 day |
| 7 | NLP | NLP | - | T+I | VANC + CTZ + DEX | Enuc (44) | None | Enuc | 2 mos |
| 8 | 20/50 | CF | 16 | T+I | VANC + CTZ | None | None | CF | 10 mos |
| 9 | 6/200 | LP | - | PPV | VANC + CTZ + DEX | None | None | 5/200 | 5 mos |
| 10 | 20/30 | HM | 33 | PPV | VANC + CTZ + DEX | None | None | 20/30 | 1 mos |
CF = count fingers, CTZ = ceftazidime, DEX = dexamethasone, Enuc = enucleation, HM = hand motion, LP = light perception, mos = months, NLP = no light perception, No. = number, PPV = pars plana vitrectomy, T + I = vitreous tap + intravitreal injection, Tx = treatment, VAN = vancomycin, VA = visual acuity, UK = unknown.